Sifalimumab (MEDI-545) is an anti-IFNalpha monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNalpha) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research[1][2].
Molecular Weight:
(144.24 kDa)
Purity:
99.46
CAS Number:
[1006877-41-3]
Target:
IFNAR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted